These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 27973759)

  • 21. An update on the implications of cyclin D1 in melanomas.
    González-Ruiz L; González-Moles MÁ; González-Ruiz I; Ruiz-Ávila I; Ayén Á; Ramos-García P
    Pigment Cell Melanoma Res; 2020 Nov; 33(6):788-805. PubMed ID: 32147907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression status of Pin1 and cyclins in oral squamous cell carcinoma: Pin1 correlates with Cyclin D1 mRNA expression and clinical significance of cyclins.
    Miyashita H; Uchida T; Mori S; Echigo S; Motegi K
    Oncol Rep; 2003; 10(4):1045-8. PubMed ID: 12792768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toll-like receptor-9 agonists increase cyclin D1 expression partly through activation of activator protein-1 in human oral squamous cell carcinoma cells.
    Min R; Siyi L; Wenjun Y; Shengwen L; Ow A; Lizheng W; Chenping Z
    Cancer Sci; 2012 Nov; 103(11):1938-45. PubMed ID: 22853846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cortactin is a prognostic marker for oral squamous cell carcinoma and its overexpression is involved in oral carcinogenesis.
    Liu YC; Ho HC; Lee MR; Yeh CM; Tseng HC; Lin YC; Chung JG
    Environ Toxicol; 2017 Mar; 32(3):799-812. PubMed ID: 27148699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin D1 and cyclin D-dependent kinases enhance oral keratinocyte proliferation but do not block keratinocyte differentiation.
    Woods M; Pant R; Mallya SM
    Int J Oncol; 2010 Dec; 37(6):1471-5. PubMed ID: 21042715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck.
    Holley SL; Parkes G; Matthias C; Bockmühl U; Jahnke V; Leder K; Strange RC; Fryer AA; Hoban PR
    Am J Pathol; 2001 Nov; 159(5):1917-24. PubMed ID: 11696452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diagnostic value of 11q13 amplification and protein expression in the detection of nodal metastasis from oral squamous cell carcinoma: a systematic review and meta-analysis.
    Noorlag R; van Kempen PM; Stegeman I; Koole R; van Es RJ; Willems SM
    Virchows Arch; 2015 Apr; 466(4):363-73. PubMed ID: 25663615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclin D1 A870G polymorphism and amplification in laryngeal squamous cell carcinoma: implications of tumor localization and tobacco exposure.
    Monteiro E; Varzim G; Pires AM; Teixeira M; Lopes C
    Cancer Detect Prev; 2004; 28(4):237-43. PubMed ID: 15350626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Daxx and TCF4 interaction links to oral squamous cell carcinoma growth by promoting cell cycle progression via induction of cyclin D1 expression.
    Lin GJ; Huang YS; Lin CK; Huang SH; Shih HM; Sytwu HK; Chen YW
    Clin Oral Investig; 2016 Apr; 20(3):533-40. PubMed ID: 26205068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of copy number amplification of cyclin D1 (CCND1) and cortactin (CTTN) in oral carcinoma and oral brushed samples from areca chewers.
    Liu HS; Lu HH; Lui MT; Yu EH; Shen W; Chen YP; Chang KW; Tu HF
    Oral Oncol; 2009 Dec; 45(12):1032-6. PubMed ID: 19666237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers.
    Ahlin C; Lundgren C; Embretsén-Varro E; Jirström K; Blomqvist C; Fjällskog M-
    Breast Cancer Res Treat; 2017 Aug; 164(3):667-678. PubMed ID: 28528450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deregulated cyclin D1 expression is associated with decreased efficacy of the selective epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in head and neck squamous cell carcinoma cell lines.
    Kalish LH; Kwong RA; Cole IE; Gallagher RM; Sutherland RL; Musgrove EA
    Clin Cancer Res; 2004 Nov; 10(22):7764-74. PubMed ID: 15570011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basic helix-loop-helix transcription factor DEC1 negatively regulates cyclin D1.
    Bhawal UK; Sato F; Arakawa Y; Fujimoto K; Kawamoto T; Tanimoto K; Ito Y; Sasahira T; Sakurai T; Kobayashi M; Kashima I; Kijima H; Kuniyasu H; Abiko Y; Kato Y; Sato S
    J Pathol; 2011 Jul; 224(3):420-9. PubMed ID: 21506129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification.
    Izzo JG; Papadimitrakopoulou VA; Li XQ; Ibarguen H; Lee JS; Ro JY; El-Naggar A; Hong WK; Hittelman WN
    Oncogene; 1998 Nov; 17(18):2313-22. PubMed ID: 9811462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A differential PCR system for the determination of CCND1 (cyclin D1) gene amplification in head and neck squamous cell carcinomas.
    Schneeberger C; Eder S; Swoboda H; Ullrich R; Zeillinger R
    Oral Oncol; 1998 Jul; 34(4):257-60. PubMed ID: 9813719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Operculina turpethum extract inhibits growth and proliferation by inhibiting NF-κB, COX-2 and cyclin D1 and induces apoptosis by up regulating P53 in oral cancer cells.
    Arora R; Bharti V; Gaur P; Aggarwal S; Mittal M; Das SN
    Arch Oral Biol; 2017 Aug; 80():1-9. PubMed ID: 28351666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescence in situ hybridization for detecting genomic alterations of cyclin D1 and p16 in oral squamous cell carcinomas.
    Uzawa N; Sonoda I; Myo K; Takahashi K; Miyamoto R; Amagasa T
    Cancer; 2007 Nov; 110(10):2230-9. PubMed ID: 17893905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclin-D1-gene amplification is a more potent prognostic factor than its protein over-expression in human head-and-neck squamous-cell carcinoma.
    Kyomoto R; Kumazawa H; Toda Y; Sakaida N; Okamura A; Iwanaga M; Shintaku M; Yamashita T; Hiai H; Fukumoto M
    Int J Cancer; 1997 Dec; 74(6):576-81. PubMed ID: 9421351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification.
    Shuster MI; Han L; Le Beau MM; Davis E; Sawicki M; Lese CM; Park NH; Colicelli J; Gollin SM
    Genes Chromosomes Cancer; 2000 Jun; 28(2):153-63. PubMed ID: 10825000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of CCND1 +870A>G and VEGF +936C>T polymorphisms on oral cancer development and disease-free survival in a Taiwan population.
    Lin YC; Yeh CJ; Wang LH; Lee CW; Chen CH
    Oral Oncol; 2012 Jun; 48(6):535-40. PubMed ID: 22321253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.